Asset Allocation

As of November 30, 2025.
Type % Net
Cash 3.00%
Stock 95.94%
Bond 0.36%
Convertible 0.00%
Preferred 0.53%
Other 0.18%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 53.16%
Mid 24.01%
Small 22.83%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 93.48%    % Emerging Markets: 5.87%    % Unidentified Markets: 0.65%

Americas 30.41%
30.37%
Canada 5.19%
United States 25.18%
0.04%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 41.50%
United Kingdom 10.73%
30.77%
Belgium 0.29%
Denmark 1.73%
France 8.01%
Germany 4.57%
Ireland 1.53%
Netherlands 8.29%
Norway 0.01%
Spain 1.24%
Switzerland 5.10%
0.00%
0.00%
Greater Asia 27.44%
Japan 7.18%
3.60%
Australia 3.60%
10.80%
Hong Kong 6.58%
Singapore 2.01%
South Korea 2.21%
5.87%
China 5.07%
Kazakhstan 0.80%
Unidentified Region 0.65%

Stock Sector Exposure

Cyclical
44.20%
Materials
8.14%
Consumer Discretionary
25.49%
Financials
10.57%
Real Estate
0.00%
Sensitive
34.75%
Communication Services
0.00%
Energy
0.00%
Industrials
23.74%
Information Technology
11.02%
Defensive
16.99%
Consumer Staples
4.72%
Health Care
9.95%
Utilities
2.31%
Not Classified
4.06%
Non Classified Equity
0.80%
Not Classified - Non Equity
3.26%
As of November 30, 2025
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available